China Cancer Drug Market will reach US$ 30.5 Billion by 2025 - Renub Research

1
China Cancer Drugs Market
China Cancer Drugs Market
2
Report Description and Highlights
China Cancer Drugs Market, by Drugs,
Cancer (Lung, Stomach, Breast, Esophageal, Liver
Others), Therapy, Companies (Merck, Celgene,
Eli Lilly, Roche Sino BioPharma) provides a
complete analysis of China Anti-Cancer Drugs
Market. According to Renub Research, China
Cancer Drug Market will reach US 30.5 Billion by
the end of the year 2025. The core factors that
will support the market growth are rising
healthcare infrastructure, increasing cancer
testing center, increasing prevalence of cancer
disease in China, the launch of various effective
cancer drugs in the Chinese market. Growth in
demand for targeted drug therapy, increasing per
capita income, rising out of pocket expenditure,
people awareness regarding the risk of various
cancer, technology advancement are some other
factors driving the demand for cancer drugs in
China. Although the negative news is that the
mortality rate of cancer patients is growing in
China as the cost of a cancer drug is quite high,
and there are many side effects of these cancer
drugs. Moreover, due to a change in food habits
lifestyle, the aging population, tobacco smoking,
the problem is growing.
China Cancer Drugs Market
3
China Cancer Drugs Market
In terms of mortality, cancer is the
second-largest disease in the world. As China is
the most populous country in the world, the risk
and prevalence rate is increasing at a rapid
pace. Per capita income of China are rising since
long period of time, people prefer urbanization
and western-style food habits. Due to increasing
urbanization, the number of smokers rises leads
to an increase in the risk of cancer. Being the
most significant emerging economies expanding the
number of cancer drug products in China will
further boost the market in the coming future.
Targeted drug therapy is most prevalent in China
because of lower side effects.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lchina-cancer-drugs-market-p.php
China Cancer Drugs Market
4
China Cancer Drugs Market
China Cancer Drug Market - By Drug Type In this
section of the report, the market is divided into
six parts Monoclonal Antibiotics, Targeted
Drugs, Hormonal Drugs, Cytotoxic Drugs,TCM, and
Others. The class of cytotoxic drugs is further
classified into three parts antimetabolites,
alkaloids of plants, and alkylating agents.
Currently, targeted drugs have more ability to
kill malignant cells, and they are quite
successful due to higher success rates and
effectiveness. Market by Cancer Type In this
study, we have conducted an in-depth market
analysis by cancer types Lung, Stomach, Breast,
Esophageal, Liver, Others. Lung cancer
constitutes the largest market share because of
the high prevalence rate and the increasing
smoker population in China.
China Cancer Drugs Market
5
China Cancer Drugs Market
Market by Therapy Targeted drug therapy is
growing significantly in China because of its
higher effectiveness and success rate than other
therapies, according to Renub Research Analysis.
In this research, we have assessed a
multi-dimensional approach to study each and
every cancer therapy that constitutes numerous
variables such as core factors supporting market
growth, opportunities assessment by each therapy,
various challenges that occurred in cancer
therapy, etc. Key Players Analysis In this
section of the report, we have done a complete
analysis of top key players. The topmost key
players are Merck, Celgene, Eli Lilly, Roche,
and Sino BioPharma. The report includes business
overview, historical revenue analysis forecast,
the strategy of the company, and recent
development, etc.
Request a free Brochure copy of the report
https//www.renub.com/request-sample-page.php?gtur
lchina-cancer-drugs-market-p.php
China Cancer Drugs Market
6
Key Topics Covered in China Cancer Drugs Market

• Key Topics Covered
•    Introduction
• 2.    Research Methodology
• 3.    Executive Summary
• 4.    China Cancer Drugs Market
• 5.    Market Share China Anti-Cancer Drugs
• 5.1    By Drugs 5.2    By Cancer5.3    By
  Therapy
• 6.    Drugs China Cancer Market
• 6.1    Cytotoxic Drugs 6.2    Targeted
  Drugs6.3    Monoclonal Antibiotics 6.4  
   Hormonal Drugs6.5    Traditional Chinese
  Medicine 6.6    Others

China Cancer Drugs Market
7
Key Topics Covered in China Cancer Drugs Market
7.    Cancer Type Market 7.1    Lung
Cancer 7.2    Stomach Cancer7.3    Breast
Cancer 7.4    Esophageal Cancer7.5    Liver
Cancer 7.6    Others 8.    Therapy China
Cancer Market 8.1    Chemotherapy 8.2  
 Targeted Therapy8.3    Hormonal Therapy 8.4  
 Others 9.    Company Analysis 9.1  
 Merck 9.2    Celgene9.3    Eli Lilly 9.4  
 Roche9.5    Sino BioPharma
China Cancer Drugs Market
8
Key Topics Covered in China Cancer Drugs Market
10.    Growth Drivers 10.1    Growing Awareness
towards Cancer Diagnosis and Treatment10.2  
 Increasing Use of Targeted Therapy10.3  
 Increasing Research and Development
Activities10.4    Cutting Import Duties on
Cancer Drugs 11.    Challenges 11.1    High
Cost of Cancer Drugs11.2    Major Side Effects
of Cancer Treatment
China Cancer Drugs Market
9
China Cancer Drugs Market
Browse Related Report Diabetes Drug
Market Epilepsy Drugs Market Contact Us Tel
1-678-302-0700 (US), 91-120-421-9822
(INDIA) Email info_at_renub.com
China Cancer Drugs Market